Literature DB >> 11776478

Genomic expression analysis implicates Wnt signaling pathway and extracellular matrix alterations in hepatic specification and differentiation of murine hepatic stem cells.

C Plescia1, C Rogler, L Rogler.   

Abstract

HBC-3 hepatic stem cells maintained in the undifferentiated state can be induced to differentiate along the hepatocyte lineage in response to DMSO (Rogler, 1997). In order to understand the complex transcriptional regulatory mechanisms associated with the differentiation of these somatic stem cells and to identify novel candidate stem cell and differentiation associated genes, we have begun to characterize the transcriptome of HBC-3 cells during a 7-day differentiation protocol. This analysis showed that differentiating HBC-3 cells undergo biphasic bursts of gene regulation peaking at 3 hours and 120 hours of DMSO treatment. In the undifferentiated state, HBC-3 cells express muscle, neuron, myeloid, and lymphoid specific genes that are rapidly downregulated during hepatocytic differentiation. Cluster analysis has revealed large groups of genes with different temporal regulation profiles demonstrating complex and widespread transcriptional changes. Specifically, we discovered a multifaceted downregulation of the Wnt/beta-catenin pathway accompanied by the repression of TCF target genes during HBC-3 differentiation. In addition, there is downregulation of cellular receptors for fibronectin and laminin and other extracellular matrix molecules indicative of widespread cell surface alterations. DMSO induces cell cycle arrest, and this is reflected in upregulation of growth inhibitory proteins such as cyclin I and p18 and downregulation of cyclins B1 and D. Genes needed for hepatocytic functions, such as apolipoprotein C-IV, phosphoenolpyruvate carboxykinase, alcohol dehydrogenase, and asialoglycoprotein receptor were upregulated. Finally, transcriptional regulators including Twist, Snail, HNF1a, and GATA6 were upregulated during differentiation of HBC-3 cells. The significance of these findings is that our genome-based approach has allowed the parallel identification of multiple regulatory pathways that is needed to begin to fully understand the complex differentiation process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11776478     DOI: 10.1046/j.1432-0436.2001.680413.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  6 in total

1.  RNA expression microarrays (REMs), a high-throughput method to measure differences in gene expression in diverse biological samples.

Authors:  Charles E Rogler; Tatyana Tchaikovskaya; Raquel Norel; Aldo Massimi; Christopher Plescia; Eugeny Rubashevsky; Paul Siebert; Leslie E Rogler
Journal:  Nucleic Acids Res       Date:  2004-08-25       Impact factor: 16.971

Review 2.  Cancer stem cells in human gastrointestinal cancers.

Authors:  Naotsugu Haraguchi; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Tohru Utsunomiya; Atsushi Sasaki; Masaki Mori
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

3.  Omentum facilitates liver regeneration.

Authors:  Ashok K Singh; Nishit Pancholi; Jilpa Patel; Natalia O Litbarg; Krishnamurthy P Gudehithlu; Perianna Sethupathi; Mark Kraus; George Dunea; Jose Al Arruda
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 4.  Stem cells, cell transplantation and liver repopulation.

Authors:  Michael Oertel; David A Shafritz
Journal:  Biochim Biophys Acta       Date:  2007-12-23

5.  Comparison of the transcriptomes of mouse skin derived precursors (SKPs) and SKP-derived fibroblasts (SFBs) by RNA-Seq.

Authors:  Yujie Mao; Lidan Xiong; Siyu Wang; Jianqiao Zhong; Rongying Zhou; Li Li
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

Review 6.  Unbalanced distribution of materials: the art of giving rise to hepatocytes from liver stem/progenitor cells.

Authors:  Wei-Hui Liu; Li-Na Ren; Tao Chen; Nan You; Li-Ye Liu; Tao Wang; Hong-Tao Yan; Hao Luo; Li-Jun Tang
Journal:  J Cell Mol Med       Date:  2013-11-28       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.